Showing results (1-10 of 746) with videos related to

Sort By:
Pageof 75
Diabetes, Obesity & Metabolism|June 10, 2017
Prevention of cardiovascular disease through reduction of glycaemic exposure in type 2 diabetes: A perspective on glucose-lowering interventionsRonan Roussel, Philippe Gabriel Steg, Kamel Mohammedi, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|April 12, 2016
Future of the Prevention and Treatment of Coronary Artery DiseasePhilippe Gabriel Steg, Grégory Ducrocq
La Revue Du Praticien|May 17, 2003
[Acute coronary syndrome with ST-segment elevation]Olivier Varenne, Philippe Gabriel Steg
Archives of Cardiovascular Diseases|September 16, 2015
Treating coronary artery disease in patients with a history of cerebrovascular diseaseGregory Ducrocq, Philippe Gabriel Steg
Current Atherosclerosis Reports|October 9, 2024
PCSK9 Monoclonal Antibodies Have Come a Long WaySandra Zendjebil, Philippe Gabriel Steg
European Cardiology|March 18, 2020
Direct-acting Anticoagulants in Chronic Coronary SyndromesEmmanuel Sorbets, Philippe Gabriel Steg
Archives of Internal Medicine|July 14, 2004
Implications of diabetes in patients with acute coronary syndromes. The Global Registry of Acute Coronary EventsKristen Franklin, Robert J Goldberg, Frederick Spencer, et al.
Lancet (London, England)|March 18, 2015
Clinical evidence for oral antiplatelet therapy in acute coronary syndromesStephen D Wiviott, Philippe Gabriel Steg
Heart (British Cardiac Society)|March 13, 2017
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high vascular riskLouis Potier, Ronan Roussel, Yedid Elbez, et al.
Pageof 75